Yin M. Lee
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Serum lipidomic signatures in patients with varying histological severity of metabolic-dysfunction associated steatotic liver disease.
Journal: Metabolism: clinical and experimental
Published: May 03, 2024
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferon.
Journal: Antiviral research
Published: October 20, 2023
Interferon shrinks spleen in pregnant patient with myeloproliferative neoplasm.
Journal: Lancet (London, England)
Published: July 20, 2022
Switching to or Add-on Peginterferon in Patients on Nucleos(t)ide Analogues for Chronic Hepatitis B: The SWAP RCT.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 04, 2021
Comparative biomarkers for HBsAg loss with antiviral therapy shows dominant influence of quantitative HBsAg (qHBsAg).
Journal: Alimentary pharmacology & therapeutics
Published: September 04, 2020
Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population.
Journal: World journal of hepatology
Published: July 07, 2020
Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.
Journal: JMIR mHealth and uHealth
Published: December 23, 2019
Identifying Patients With Cirrhosis Who Might Avoid Screening Endoscopy Based on Serum Albumin and Bilirubin and Platelet Counts.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 25, 2019
Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection.
Journal: World journal of hepatology
Published: February 12, 2019
Findings from a large Asian chronic hepatitis C real-life study.
Journal: Journal of viral hepatitis
Published: December 08, 2017
Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-Pacific hepatitis C virus genotype 1 non-responders/relapsers.
Journal: World journal of gastroenterology
Published: September 10, 2014
Liver disease progression and virological response: entecavir rescue still possible in the setting of rtM204I lamivudine-resistant mutation.
Journal: Gut
Published: November 13, 2012
Last Updated: 09/26/2026